FREMONT, Calif., Sept. 21 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. announced today that Mark McDade, Chief Executive Officer, will participate in upcoming investor conferences. These conferences are:
* The Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference in London on Friday, September 22, at 2:10 p.m. GMT, 9:10 a.m. EDT. * The UBS Global Life Sciences Conference in New York on Monday, September 25 at 10:30 a.m. EDT.
Live webcasts of these presentations will be available to all interested parties through the PDL website at www.pdl.com . Please connect to this website at least 15 minutes prior to the live webcasts to allow time for any software download that may be needed to hear them. Replays of the presentations will be available at www.pdl.com starting approximately two hours after completion of the live webcast, and will remain available for 30 days thereafter.
About PDL BioPharma
PDL BioPharma, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life- threatening illnesses. The company currently markets and sells a portfolio of leading products in the acute-care hospital setting in the United States and Canada and generates royalties through licensing agreements with top-tier biotechnology and pharmaceutical companies based on its pioneering antibody humanization technology. Currently, PDL’s diverse product pipeline includes investigational compounds in Phase 2 or Phase 3 clinical development for inflammation and autoimmune diseases, cardiovascular disorders and cancer. The company’s research platform is focused on the discovery and development of antibodies for the treatment of cancer and autoimmune diseases. For more information, please see PDL’s website at www.pdl.com .
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.
PDL BioPharma, Inc.
CONTACT: Ami Knoefler, Corporate and Investor Relations of PDL BioPharma,Inc., +1-510-284-8851, or ami.knoefler@pdl.com
Web site: http://www.pdl.com/
